Fraction of U.S. Outpatient Treatment Centers Offer Medication for Opioid Addiction
Johns Hopkins Bloomberg School of Public HealthDespite the mounting death toll of America’s opioid crisis, only a minority of facilities that treat substance use disorders offer patients buprenorphine, naltrexone or methadone—the three FDA-approved medications for the long-term management of opioid use disorder, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.